Security record · archived quarter
AMED
Amedisys, Inc. · Healthcare · Medical - Care Facilities
14Tracked holders
0Δ holders
4.70MShares held
$426.69MReported value
+0New positions
−0Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +14.7% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2025 | 16 | 0 | 10.65M | $1.05B | — | — |
| Q1 2025 | 13 | -1 | 4.60M | $426.27M | — | −1 |
| Q4 2024 | 14 | 0 | 4.70M | $426.69M | — | — |
| Q3 2024 | 13 | 0 | 3.10M | $299.50M | +1 | −1 |
| Q2 2024 | 13 | — | 2.58M | $236.78M | — | — |
Who holds it · Q4 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 993.76K | — | $90.22M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Norges Bank ✦ (passive) | 914.86K | +134.9% | $83.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 872.96K | +44.5% | $79.26M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 872.96K | +44.5% | $79.26M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 573.02K | +1.0% | $52.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 573.02K | +1.0% | $52.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Adage Capital Partners ✦ | 418.00K | +32.3% | $37.95M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | Millennium Management ✦ | 385.57K | -29.2% | $35.01M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Gotham Asset Management ✦ | 246.92K | +77.4% | $22.42M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 10 | Marshall Wace ✦ | 194.60K | -43.1% | $17.67M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Marshall Wace ✦ | 194.60K | -43.1% | $17.67M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 194.60K | -43.1% | $17.67M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 35.80K | -70.2% | $3.25M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | GAMCO Investors ✦ | 30.33K | +0.5% | $2.75M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 18.30K | +9.8% | $1.66M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 6.76K | -5.7% | $613,562 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 6.76K | -5.7% | $613,562 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 4.98K | -63.3% | $451,771 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 3.69K | -71.3% | $334,652 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 1 shares, $101 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q4 2024 ·
Methodology ·
Get this via the API